UPCOMING EVENTS & DEADLINES
For more photonics conference, check out these sites.
-
Luis Arnaut, PhD elected as the next President of the International Photodynamic Association (IPA) Board of Direct… https://t.co/XH9YaUvLXh -
To help the IPA Board of Directors best represent and advance the goals of the IPA membership, we ask your help in… https://t.co/Xm4DVR4F5M
-
To help the IPA Board of Directors best represent and advance the goals of the IPA membership, we ask your help in… https://t.co/5JdOHnDydo
-
RT @POLYTHEA1: To celebrate the International Year of the Periodic Table our #ESR decided to shine light on the elements which mak… https://t.co/33IXJMZepk
-
Congratulations to the new IPA Board of Directors! Thank you to all 40 members who were nominated and ran in this c… https://t.co/209TEzsJa9
-
RT @oncothai: « Développement d’un dispositif textile lumineux pour le traitement de la carcinose péritonéale d’origine ovarienne… https://t.co/e2URADAOSN
-
RT @Sabrina_MTT: Great collaboration between @UUBeta and @VUamsterdam leading to nice work! Just accepted in @Mol_Pharm “Nanobody-ta… https://t.co/O9ZluZvKdP
-
Australian Investigators Use Investigational Photodynamic Drug to Treat Cancer - Research team is utilizing a new p… https://t.co/OfTsPnglJD
-
Engineering the phototropin photocycle improves photoreceptor performance and plant biomass production https://t.co/SjJRJwTE0r
-
RT @EurSocPhotobiol: It’s still possible to register for the most exciting, interdisciplinary #photobiology research congress of the yea… https://t.co/gcsdIDf4Z8
-
Ondine Biomedical - created light-based treatment with global impact that can eradicate bacteria, viruses, fungi fr… https://t.co/FeL2Fg7V2R
-
RT @SPIEevents: 📢 Jack Szostak, @NobelPrize winner in #Physiology or Medicine, will be a plenary speaker at #IPABoston2019! We lo… https://t.co/vczilf3x76
-
RT @EurSocPhotobiol: We are pleased to announce the 2019 ESP Young Investigator Award winners Dr. Pilar Acedo (University College London… https://t.co/VxrmRU92kU
-
RT @SPIEevents: We look forward to welcoming Jack Szostak as a plenary speaker at #IPABoston2019 this July in Boston, MA!… https://t.co/Z5DYr8EhQW
-
RT @Fab_Dumoulin: Hey scientists from everywhere 👩🏻🔬👨🏾🔬! 📢Deadline for @MSCActions individual fellowships is Sept 11.… https://t.co/nTIllEzL9E
-
RT @photodynamicIPA: Voting now open for IPA Board of Director Seats. All IPA members are eligible to vote. Voting ends June 7, 2019.… https://t.co/7n5QMUyRgU
International Photodynamic Association (IPA)
The IPA was founded in 1986 with membership consisting of prominent international scientists, health care professionals, students, and fellows researching photodynamic therapy (PDT) and photodiagnosis (PD). The IPA's purpose is to promote the study of diagnosis and treatment using light activated photosensitisers and to disseminate scientific information to its members, the research community, and to the community at large. The IPA organizes a Biennial World Congress, providing a unique opportunity to share data and listen to cutting edge discoveries surrounding PDT.
Please join us for the
17th International Photodynamic Association World Congress #IPABoston2019
Bringing together researchers and clinicians in all fields of photodynamic therapy (PDT) and photodiagnosis (PD) since 1986. Every two years, the IPA organizes a conference to foster scientific development and contribute to clinical practice. The 17th IPA World Congress in conjunction with SPIE will be in Cambridge, MA from June 28 - July 4, 2019. We welcome you to Boston in 2019.
Conference Chair: Tayyaba Hasan, PhD - Professor at the Wellman Center for Photomedicine, Harvard Medical School and a Professor of Health Sciences and Technology (Harvard-MIT).
Awards for excellence in Photodynamic Research and Practice to be announced at the IPA Congress. Nominations now open through May 7, 2019.
WHAT IS PDT and PD?
Photodynamic therapy (PDT) employs light-sensitive compounds known as photosenstizers (PSs) that when exposed selectively to light in conjunction with molecular oxygen become toxic to cells resulting in cell death. Many PSs exist today including: cationic dyes such as methylene blue, tetrapyrrole derivatives (phthalocyanines, chlorins, porphyrins), chlorophyll derivatives, and functionalized fullerenes.
PDT, a minimally invasive treatment option, is used to treat many conditions including: acne, psoriasis, age related macular degeneration, and several cancers such as skin, lung, brain, bladder, bile-duct, esophageal, and head and neck cancers. PDT is also proven to eradicate pathogenic microorganisms Gram-positive and Gram-negative bacteria, yeasts and fungi.
Photodiagnosis (PD), also known as Photodynamic Diagnosis (PDD) is the use of light-sensitive compounds to indicate the presence of cancerous or diseased tissue. The same photosensitizers that are used for the treatment of cancer can also assist in its diagnosis. The emitted fluorescence from the activated photosensitizer can be used to differentiate cancerous from normal tissue guiding physicians during surgical resection.
To learn more about the basics of photomedicine, the American Society for Photobiology (ASP) has a great free resource available on line.
